Annual Operating Profit
-$150.92 M
-$50.09 M-49.68%
December 1, 2024
Summary
- As of February 22, 2025, VKTX annual operating income is -$150.92 million, with the most recent change of -$50.09 million (-49.68%) on December 1, 2024.
- During the last 3 years, VKTX annual operating profit has fallen by -$95.24 million (-171.04%).
- VKTX annual operating profit is now -149178.93% below its all-time high of -$101.10 thousand, reached on December 31, 2013.
Performance
VKTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$46.24 M
-$9.68 M-26.49%
December 1, 2024
Summary
- As of February 22, 2025, VKTX quarterly operating income is -$46.24 million, with the most recent change of -$9.68 million (-26.49%) on December 1, 2024.
- Over the past year, VKTX quarterly operating profit has dropped by -$16.95 million (-57.89%).
- VKTX quarterly operating profit is now -1444837.50% below its all-time high of -$3200.00, reached on March 31, 2013.
Performance
VKTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$150.92 M
-$16.95 M-12.65%
December 1, 2024
Summary
- As of February 22, 2025, VKTX TTM operating income is -$150.92 million, with the most recent change of -$16.95 million (-12.65%) on December 1, 2024.
- Over the past year, VKTX TTM operating profit has dropped by -$50.09 million (-49.68%).
- VKTX TTM operating profit is now -137601.64% below its all-time high of -$109.60 thousand, reached on December 31, 2012.
Performance
VKTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
VKTX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.7% | -57.9% | -49.7% |
| 3 y3 years | -171.0% | -269.6% | -171.0% |
| 5 y5 years | -361.7% | -421.1% | -361.7% |
VKTX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -171.0% | at low | -269.6% | at low | -171.0% | at low |
| 5 y | 5-year | -361.7% | at low | -421.1% | at low | -361.7% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
Viking Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$150.92 M(+49.7%) | -$46.24 M(+26.5%) | -$150.92 M(+12.7%) |
| Sep 2024 | - | -$36.56 M(+7.3%) | -$133.97 M(+7.5%) |
| Jun 2024 | - | -$34.05 M(-0.1%) | -$124.68 M(+9.0%) |
| Mar 2024 | - | -$34.07 M(+16.3%) | -$114.36 M(+13.4%) |
| Dec 2023 | -$100.83 M(+43.3%) | -$29.29 M(+7.4%) | -$100.83 M(+9.8%) |
| Sep 2023 | - | -$27.27 M(+14.8%) | -$91.83 M(+13.7%) |
| Jun 2023 | - | -$23.74 M(+15.6%) | -$80.76 M(+8.2%) |
| Mar 2023 | - | -$20.54 M(+1.3%) | -$74.65 M(+6.1%) |
| Dec 2022 | -$70.36 M(+26.4%) | -$20.28 M(+25.2%) | -$70.36 M(+12.4%) |
| Sep 2022 | - | -$16.20 M(-8.1%) | -$62.58 M(+4.7%) |
| Jun 2022 | - | -$17.63 M(+8.5%) | -$59.79 M(+3.6%) |
| Mar 2022 | - | -$16.25 M(+29.9%) | -$57.70 M(+3.6%) |
| Dec 2021 | -$55.68 M(+30.5%) | -$12.51 M(-6.7%) | -$55.68 M(+2.3%) |
| Sep 2021 | - | -$13.40 M(-13.8%) | -$54.44 M(+7.0%) |
| Jun 2021 | - | -$15.54 M(+9.2%) | -$50.88 M(+10.7%) |
| Mar 2021 | - | -$14.23 M(+26.3%) | -$45.94 M(+7.7%) |
| Dec 2020 | -$42.66 M(+30.5%) | -$11.27 M(+14.5%) | -$42.66 M(+5.9%) |
| Sep 2020 | - | -$9.84 M(-7.2%) | -$40.27 M(+6.3%) |
| Jun 2020 | - | -$10.61 M(-3.1%) | -$37.87 M(+2.8%) |
| Mar 2020 | - | -$10.95 M(+23.4%) | -$36.83 M(+12.7%) |
| Dec 2019 | -$32.69 M(+24.9%) | -$8.87 M(+19.3%) | -$32.69 M(+6.0%) |
| Sep 2019 | - | -$7.44 M(-22.3%) | -$30.85 M(+0.1%) |
| Jun 2019 | - | -$9.57 M(+40.6%) | -$30.81 M(+9.4%) |
| Mar 2019 | - | -$6.81 M(-3.3%) | -$28.16 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$26.16 M(+37.2%) | -$7.04 M(-4.8%) | -$26.16 M(+11.1%) |
| Sep 2018 | - | -$7.39 M(+6.8%) | -$23.55 M(+13.0%) |
| Jun 2018 | - | -$6.92 M(+44.1%) | -$20.85 M(+10.3%) |
| Mar 2018 | - | -$4.80 M(+8.5%) | -$18.91 M(-0.9%) |
| Dec 2017 | -$19.07 M(+37.7%) | -$4.43 M(-5.6%) | -$19.07 M(+3.8%) |
| Sep 2017 | - | -$4.69 M(-5.8%) | -$18.38 M(+8.4%) |
| Jun 2017 | - | -$4.98 M(+0.3%) | -$16.95 M(+9.0%) |
| Mar 2017 | - | -$4.97 M(+32.9%) | -$15.55 M(+12.3%) |
| Dec 2016 | -$13.85 M(+15.4%) | -$3.74 M(+14.5%) | -$13.85 M(-6.0%) |
| Sep 2016 | - | -$3.26 M(-8.8%) | -$14.73 M(-6.5%) |
| Jun 2016 | - | -$3.58 M(+9.5%) | -$15.75 M(+6.4%) |
| Mar 2016 | - | -$3.27 M(-29.3%) | -$14.80 M(+23.4%) |
| Dec 2015 | -$12.00 M(-48.9%) | -$4.62 M(+7.7%) | -$12.00 M(+55.2%) |
| Sep 2015 | - | -$4.29 M(+63.2%) | -$7.73 M(+68.4%) |
| Jun 2015 | - | -$2.63 M(+469.8%) | -$4.59 M(-80.6%) |
| Mar 2015 | - | -$461.00 K(+30.4%) | -$23.72 M(+1.1%) |
| Dec 2014 | -$23.47 M(>+9900.0%) | -$353.60 K(-69.2%) | -$23.47 M(+1.5%) |
| Sep 2014 | - | -$1.15 M(-94.7%) | -$23.11 M(+5.2%) |
| Jun 2014 | - | -$21.76 M(>+9900.0%) | -$21.97 M(+9589.1%) |
| Mar 2014 | - | -$209.70 K(+1133.5%) | -$226.70 K(+74.7%) |
| Dec 2013 | -$101.10 K | - | - |
| Jun 2013 | - | -$17.00 K(+431.3%) | -$129.80 K(+15.1%) |
| Mar 2013 | - | -$3200.00(-97.1%) | -$112.80 K(+2.9%) |
| Dec 2012 | - | -$109.60 K | -$109.60 K |
FAQ
- What is Viking Therapeutics annual operating income?
- What is the all time high annual operating profit for Viking Therapeutics?
- What is Viking Therapeutics annual operating profit year-on-year change?
- What is Viking Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Viking Therapeutics?
- What is Viking Therapeutics quarterly operating profit year-on-year change?
- What is Viking Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Viking Therapeutics?
- What is Viking Therapeutics TTM operating profit year-on-year change?
What is Viking Therapeutics annual operating income?
The current annual operating profit of VKTX is -$150.92 M
What is the all time high annual operating profit for Viking Therapeutics?
Viking Therapeutics all-time high annual operating income is -$101.10 K
What is Viking Therapeutics annual operating profit year-on-year change?
Over the past year, VKTX annual operating income has changed by -$50.09 M (-49.68%)
What is Viking Therapeutics quarterly operating income?
The current quarterly operating profit of VKTX is -$46.24 M
What is the all time high quarterly operating profit for Viking Therapeutics?
Viking Therapeutics all-time high quarterly operating income is -$3200.00
What is Viking Therapeutics quarterly operating profit year-on-year change?
Over the past year, VKTX quarterly operating income has changed by -$16.95 M (-57.89%)
What is Viking Therapeutics TTM operating income?
The current TTM operating profit of VKTX is -$150.92 M
What is the all time high TTM operating profit for Viking Therapeutics?
Viking Therapeutics all-time high TTM operating income is -$109.60 K
What is Viking Therapeutics TTM operating profit year-on-year change?
Over the past year, VKTX TTM operating income has changed by -$50.09 M (-49.68%)